Axonics Inc 's ability to collect accounts receivable sequentially worsen to 7.57, indicating more challenging environment then in the second quarter 2024, but still, it is a far cry from any concerns. Average collection period, for Axonics Inc 's accounts receivable remained unchanged at 48 days, in the Sep 30 2024 quarter.

If we take a look into Healthcare sector 233 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2024 from 780 to 1794.

What is Receivable Turnover Ratio?
What is Axonics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AXNX Receivables Turnover Ratio	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter
Y / Y Receivable Change	27.99 %	20.63 %	25.69 %	27.73 %	32.42 %
Y / Y Revenue Change	25.57 %	22.87 %	29.16 %	27.92 %	30.86 %
Receivable Turnover Ratio (TTM)	7.57	7.62	7.57	7.54	7.53
AXNX's Total Ranking	# 1794	# 780	# 1659	# 1482	# 1743
Accounts Receivable average collection period days	48	48	48	48	48
Seq. Receivable Change	9.48 %	13.24 %	-11.73 %	16.96 %	3.18 %
Seq. Revenue Change	1.32 %	25.08 %	-16.97 %	19.33 %	-0.85 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 105
Healthcare Sector	# 234
Overall Market	# 1794

Receivable Turnover Ratio Statistics
High	Average	Low
0.58	0.36	0
(Sep 30 2024)		(Sep 30 2018)

AXNX Company Profile • Back to AXNX Efficiency Comparisons • Compare AXNX Receivables Turnover Ratio to its Competitors

Financial Statements
Axonics Inc 's Accounts Receivable	$ 63 Millions	Visit AXNX's Balance sheet
Axonics Inc 's Sales TTM	$ 431 Millions	Visit AXNX's Income Statement
Sources of AXNX's Revenues		Visit AXNX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AXNX's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AXNX's Growth Rates	AXNX's Roa	AXNX's Inventory Turnover Ratio	AXNX's Dividend Comparisons
AXNX's Profitability Ratios	AXNX's Roi	AXNX's Asset Turnover Ratio	AXNX's Dividend Growth
AXNX's Valuation Ratios	AXNX's Roe	AXNX's Financial Strength Ratios	AXNX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2024	Receivable at quarter ending Sep 30 2024
Kiniksa Pharmaceuticals International Plc	18.60	$ 384.098 Millions	$ 20.650 Millions
Pulmatrix Inc	18.56	$ 10.005 Millions	$ 0.539 Millions
Milestone Scientific Inc	18.54	$ 8.862 Millions	$ 0.478 Millions
Hookipa Pharma inc	17.97	$ 49.999 Millions	$ 2.782 Millions
Vireo Growth Inc.	17.70	$ 98.534 Millions	$ 5.568 Millions
Macrogenics Inc	17.38	$ 141.329 Millions	$ 8.132 Millions
Silence Therapeutics Plc	17.27	$ 43.010 Millions	$ 2.490 Millions
Innovage Holding Corp	17.01	$ 786.512 Millions	$ 46.249 Millions
Talkspace Inc	16.98	$ 179.853 Millions	$ 10.591 Millions
Scorpius Holdings inc	16.51	$ 10.044 Millions	$ 0.608 Millions
Arvinas Inc	16.48	$ 161.100 Millions	$ 9.775 Millions
Stablecoin Development Corporation	16.33	$ 11.199 Millions	$ 0.686 Millions
Nexalin Technology Inc	16.24	$ 0.162 Millions	$ 0.010 Millions
Precipio inc	16.07	$ 17.411 Millions	$ 1.084 Millions
Sangamo Therapeutics Inc	15.97	$ 52.291 Millions	$ 3.274 Millions
Icu Medical Inc	14.80	$ 2,340.754 Millions	$ 158.125 Millions
Inmed Pharmaceuticals Inc	14.57	$ 4.284 Millions	$ 0.294 Millions
Biofrontera Inc	14.26	$ 61.432 Millions	$ 4.308 Millions
Valion Bio Inc	14.02	$ 0.957 Millions	$ 0.068 Millions
Mannkind Corporation	14.00	$ 267.200 Millions	$ 19.086 Millions
Qhslab Inc	13.69	$ 1.821 Millions	$ 0.133 Millions
Pluri Inc	13.36	$ 0.598 Millions	$ 0.045 Millions
Dih Holding Us Inc	13.13	$ 116.794 Millions	$ 8.898 Millions
Patterson Companies Inc	13.07	$ 6,555.862 Millions	$ 501.549 Millions
Chemed Corporation	12.84	$ 2,377.206 Millions	$ 185.072 Millions
International Stem Cell Corporation	12.65	$ 8.528 Millions	$ 0.674 Millions
Nrc Health	12.61	$ 144.154 Millions	$ 11.436 Millions
Poseida Therapeutics Inc	12.52	$ 150.858 Millions	$ 12.053 Millions
Petvivo Holdings Inc	12.46	$ 0.969 Millions	$ 0.078 Millions
Utah Medical Products Inc	12.05	$ 43.301 Millions	$ 3.593 Millions

Date modified: 2026-09-08T15:22:13+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.